• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Nucs AI Secures $3.5M to Advance AI-Powered Prostate Cancer Diagnostics

by Syed Hamza Sohail 12/11/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– Nucs AI, a company that uses AI in precision medicine for the diagnosis and treatment of prostate cancer, today announces that it has closed a $3.5 million seed round of funding.

– The company will use the funding to further build out its platform and to support FDA clearance for its technology in the United States. 

Nucs AI: Transforming Prostate Cancer Diagnosis and Treatment with Precision Medicine

Founded in 2023, Nucs AI is pioneering advancements in prostate cancer care through the integration of precision medicine and artificial intelligence (AI). With global prostate cancer cases projected to double between 2020 and 2040, the company aims to revolutionize patient outcomes by optimizing the use of prostate-specific membrane antigen (PSMA)-targeted imaging and therapeutics.

Nucs AI offers two AI-powered tools designed to enhance clinical decision-making:

  • DeepPSMA: Employs discriminative AI for rapid, accurate detection, staging, and quantification of prostate cancer using PSMA-PET/CT imaging.
  • SelectPSMA: Predicts individual patient response to PSMA-targeted radiopharmaceuticals, aiding in personalized cancer treatment strategies.

PSMA-PET/CT imaging has become the gold standard for detecting and staging prostate cancer, offering superior accuracy compared to conventional imaging. Complementing this, PSMA-targeted radiopharmaceuticals, such as 177Lu-PSMA-617 (Pluvicto), deliver internal radiation therapy directly to prostate cancer cells, slowing or reducing tumor growth.

The American Cancer Society reports that prostate cancer is the most commonly diagnosed cancer among men, with 1.5 million global cases annually and 299,000 new cases expected in the U.S. in 2024 alone. This underscores the urgent need for innovative tools to improve care delivery and outcomes.

Nucs AI’s mission is to equip clinicians with state-of-the-art resources to streamline workflows, enhance hospital capacity, and elevate patient care standards. As highlighted by Co-Founder and CEO Nijat Ahmadov, Nucs AI focuses on enabling personalized cancer care by identifying patients most likely to benefit from advanced PSMA-targeted therapies through its proprietary SelectPSMA technology.

By integrating AI with precision medicine, Nucs AI is setting new benchmarks in the diagnosis and treatment of prostate cancer, ensuring that patients receive tailored care for optimal clinical benefit.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |